Entourage Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ENTG)
Entourage Health is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). The healthcare sector contains companies in biotechnology, pharmaceuticals, hospitals, home and long-term care as well as related medical equipment manufacturers and suppliers.
All data provided as-at market close January 22, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Entourage Health WeedMD Inc is a licensed producer and distributor of medical cannabis. WeedMD is focused on providing medicine to the long-term care and assisted living markets in Canada through its comprehensive platform. Entourage Health is listed under ENTG on the TSX Venture Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| JUMP-X | Leveljump Healthcare | 0.07 | 0 | 0 | 0 | 0 | 0 |
| MNOW-X | Mednow | 0.26 | 0 | 0 | 0 | 0 | 0 |
| CRBK-X | Carebook Technologies | 0.07 | 0 | 0 | 0 | 0 | 0 |
| SUGR-H-X | SugarBud Craft Growers | 0.11 | 0 | 0 | 0 | 0 | 0 |
| ENTG-X | Entourage Health | 0.03 | 0 | 0 | 0 | 0 | 0 |
| HMRK-X | Highmark Interactive | 0.04 | 0 | 0 | 0 | 0 | 0 |
| HITI-X | High Tide | 2.05 | 0 | 0 | 0 | 0 | 0 |
| LOTA-X | Delota | 0.14 | 0 | 0 | 0 | 0 | 0 |
| CHIP-H-X | Health Logic Interactive | 0.03 | 0 | 0 | 0 | 0 | 0 |
| NGMD-X | NuGen Medical Devices | 0.04 | 0 | 0 | 0 | 0 | 0 |
More about Entourage Health
Stocks in this category are held primarily for capital appreciation.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
